Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Appears to be old preferred shares hitting the market as note 13 explains the company has sufficient working capital until AT LEAST Q1 2020 which is more than most otc companies can say. There was 3400 preferred outstanding as of August and they are 1 for 1000 so 34Mil if they converted them all
Silverland easy
GOVX xspt & ikto my only pennies
Owned by same guys who run IGNG who just brought Justin Costello on board
Would love to get some sub penny
I mean how hard is it to file a 15-12g ?? 10 minutes and NO COST?!
This is why you should never, EVER buy delinquent tickers!!! And if you do don’t hold that crap overnight!
Nice 700k bid .007 only a matter of time
She’s s beaut have a great weekend y’all
Nice one ikto nice recovery too TA says 15bil shares officially canceled will blow up when otc mkts updated imo
Sooooo close $$$$ONPH
Looks like today
Logged off today
Nice slap
Rsi only 65 here @05
Yikes
3mil hit was that a cross ?? I’m on mobile and can’t see thanks in advance
Took a lil starter 0024&25
Alex is a meth head scam artist. He went from developing “state of the art weapons systems” to selling socks to his investors. Lol
Boom 07s going
Wow added 0007s lots of hoe traders here
04s up and thin few g’s per penny
I saw that this weekend I sent them an info request on the website to get more information
One thing everyone should keep in mind is we signed for KALOS worldwide rights.. onph didnt give up any nano smart rights
Kalos must have approached ONPH specifically for its nano smart targeted delivery system , this is not your typical stinky pinky trying to purchase someone’s drug rights..
Add me back & no rsi only 65!
Wow.. the FDA Office of Orphan Products Development (OOPD) has granted orphan drug designation for its lead product candidate, KTH-222, in the treatment of pancreatic cancer.
Kalos hope to see applications for KTH-222 in several other virulent cancers, such as ovarian, prostate and hepatic. The opportunity for KTH-222 to be used synergistically with taxanes to help in the disruption of tubulin dynamics is a key advance for the Kalos.
Tubulin disruption is the primary biochemical mechanism of action of an important class of anticancer therapy: the taxanes (e.g. Taxol, Taxotere, and Jevtana). These therapies have been used to successfully treat a number of different types of cancer in man. Although taxane therapeutics are highly active against cancer, they also have limitations to their use including a high level of toxicity and the development of tolerance. Thus, the discovery of therpies with the same mechanism as the taxanes but with reduced toxicity is a major goal in anti-cancer drug development.
Higher close than Monday straight slingshot next week
Great group 19m float no dilution upgraded to current today and cancer partnership news the other day .10 won’t be tough here
Going to get a lot of buzz over the weekend wouldn’t wanna be without some
Nothing beats a good pharma play not MJ and not even btc imo
Wouldn’t surprise me .025 already up
Oversold and razor thin here not much under 02
Nice 1m slap near hod
Why didn’t they name the company ?
Went current yesterday.. might see 01s falling today
If all those other gold tickers can see multi penny last few weeks no reason this can’t see a cent
Nice buys out the gate
Mhm left well over 100gs on the table there... that’s why you never set the bar too high and ALWAYS ride some free shares with these r/m plays !!!
Always sell the gaps bro